Pharmaceutical companies today are distributed, global organizations, with research centers, manufacturing facilities, and regulatory management hubs spread all over the globe. To develop new treatments and bring them to market, all of these different functions need to collaborate more closely than ever. Using traditional, on-premises storage technologies, however, makes it difficult to share data quickly and securely, especially given that the research and manufacturing process can generate
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Why Families Need the Closure Whole Genome Sequencing Provides
For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents of the patient, especially when searching for a diagnosis can go on for years. This is the essence of what is known as the “diagnostic odyssey.”
Honing in on a rare disease diagnosis involves thorough medical history evaluations,
Read More
Komodo Health Secures $220M for Life Sciences Data Platform at $3.3B Valuation
What You Should Know:
- Komodo Health announces $220M Series E investment to advance its enterprise healthcare and life sciences platform. At a $3.3 billion valuation, the investment underscores the company's rapidly growing role as a foundational enterprise technology platform helping to drive digital transformation across the healthcare industry.
- Founded in 2014, Komodo Health’s Healthcare Map™ is the industry’s largest and most complete record of
Read More
Variantyx Lands $20M for Whole Genome Sequencing Methodology
What You Should Know:
- Variantyx, a Boston-based provider of high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango
Read More
Exscientia Secures $100M To Expand AI Drug Discovery Platform
What You Should Know:
- Exscientia, leading AI drug discovery company, today announced that it completed its $100 million Series C financing round, with a further $30 million investment from Blackrock.
- This new capital, which will be used to support Exscientia's platform development and proprietary pipeline, follows Exscientia’s demonstrated high growth, having announced earlier this year that the first ever precision engineered drug designed using AI had entered Phase I human clinical
Read More
Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
What You Should Know:
Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.
The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds.
- OrbiMed Private Investments
Read More
Microsoft, UCB Launch Collaboration to Accelerate Drug Discovery and Development
What You Should Know:
- Global biopharma company UCB and Microsoft announced today a new, multi-year strategic collaboration to advance UCB’s digital transformation, change the way care is delivered, and accelerate better outcomes for people living with severe diseases.
- The partnership builds on the companies’ joint work as part of the COVID Moonshot project which sought to create an orally bioavailable anti-viral for COVID-19. During the project, UCB completed six
Read More
Illumina, Sequoia Capital China Launches Genomics Incubator in China
What You Should Know:
- Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics.
- Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in building genomics companies with the unparalleled track record of Illumina Accelerator in San Francisco Bay Area and Cambridge, UK.
- Sequoia Capital China will dedicate to
Read More
Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture
What You Should Know:
- Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC.
- The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to
Read More
Mammoth Biosciences, Agilent Partner on High-Throughput CRISPR-Based SARS-CoV-2 Diagnostic Test
What You Should Know:
- Mammoth Biosciences, the company bringing CRISPR out of the lab to help fight COVID-19 announced a partnership with lab giant Agilent to automate and scale its CRISPR-based high throughput testing system.
- Building on existing partnerships with Hamilton and Merck, this deal will help deliver a workflow capable of performing more than 4,000 COVID-19 tests per day.
Mammoth Biosciences, Inc. today announced a co-marketing agreement with Agilent Technologies to
Read More
